Current Neuro-Oncology

Volume 27 Number 1
10 January 2025

Home > Publications > Current Neuro-Oncology > Volume 27, Year 2025 > Number 1, 10 January

Chen CH, Hsu SY, Yu WJ, Chiang CS, Yu CF.
Distinct roles of small extracellular vesicles from resident and infiltrating macrophages on glioma growth and mobility.
J Cancer. 2025 Jan 1;16(3):969-981. doi: 10.7150/jca.103595. PMID: 39781357. Laboratory investigation. ˍ

Gao J, Gu D, Yang K, Zhang J, Lin Q, Yuan W, Zhu X, Dixit D, Gimple RC, You H, Zhang Q, Shi Z, Fan X, Wu Q, Lu C, Cheng Z, Li D, Zhao L, Xue B, Zhu Z, Zhu Z, Yang H, Zhao N, Gao W, Lu Y, Shao J, Cheng C, Hao D, Yang S, Chen Y, Wang X, Kang C, Ji J, Man J, Agnihotri S, Wang Q, Lin F, Qian X, Mack SC, Hu Z, Li C, Taylor MD, Li Y, Zhang N, Rich JN, You Y, Wang X.
Infiltrating plasma cells maintain glioblastoma stem cells through IgG-Tumor binding.
Cancer Cell. 2025 Jan 2:S1535-6108(24)00481-1. doi: 10.1016/j.ccell.2024.12.006. PMID: 39753140. Laboratory investigation˰ ˍ
RELATED ARTICLE
Kirschstein E, Gunderson AJ.
Plasma cell and cancer stem cell crosstalk in glioblastoma.
Cancer Cell. 2025 Jan 2:S1535-6108(24)00482-3. doi: 10.1016/j.ccell.2024.12.007. PMID: 39753137. Comment˰ ˍ

Licón-Muñoz Y, Avalos V, Subramanian S, Granger B, Martinez F, García-Montaño LA, Varela S, Moore D, Perkins E, Kogan M, Berto S, Chohan MO, Bowers CA, Piccirillo SGM.
Single-nucleus and spatial landscape of the sub-ventricular zone in human glioblastoma.
Cell Rep. 2025 Jan 2;44(1):115149. doi: 10.1016/j.celrep.2024.115149. PMID: 39752252. Laboratory investigation. ˍ

Lim S, Clarke NH, Maloney SL, Sener UT, Caron SJ, Kizilbash SH, Campian JL, Neth BJ, Carabenciov ID, Uhm J, Ruff MW.
Bevacizumab exerts dose-dependent risk for intracranial hemorrhage in patients with malignant gliomas.
J Neurooncol. 2025 Jan 2. doi: 10.1007/s11060-024-04916-8. PMID: 39747716. Observational study˰ ˍ

Pełka K, Koczyk K, Koperski L, Dziedzic T, Nowak A, Królicki L, Kunert P, Kunikowska J.
Imply on diagnosis and early prognosis of preoperative [⁶⁸Ga]Ga-PSMA-11 PET/CT in patients with suspected brain tumours of glial origin.
Sci Rep. 2025 Jan 2;15(1):214. doi: 10.1038/s41598-024-84036-5. PMID: 39747932. Interventional study. ˍ

Almeida ND, Rupp J, Gulzar B, Schrand TV, Madhugiri V, Fang M, Shekher R, Goulenko V, Goyal D, Prasad S, Milano MT, Prasad D.
Evaluating the impact of performance status in elderly patients with glioblastoma.
J Clin Neurosci. 2025 Jan 3;133:111028. doi: 10.1016/j.jocn.2024.111028. PMID: 39755030. Observational study. ˍ

Madlener S, Stepien N, Senfter D, Mayr L, Laemmerer A, Hedrich C, Baumgartner A, Lötsch-Gojo D, Sterba J, Pokorna P, Kiesel B, Widhalm G, Eckert F, Preusser M, Rössler K, Azizi A, Peyrl A, Czech T, Haberler C, Slavc I, Kasprian G, Dorfer C, Furtner J, Gojo J.
Detection of H3F3A K27M or BRAF V600E in liquid biopsies of brain tumor patients as diagnostic and monitoring biomarker: impact of tumor localization and sampling method.
Acta Neuropathol. 2025 Jan 3;149(1):5. doi: 10.1007/s00401-024-02842-7. PMID: 39751690. Observational study. ˍ

Chen Z, Liu H, Yang A, Liao J, Wu Z, Chen J, Miao W.
68Ga-Pentixafor PET in Combination With MRI Improves the Differential Diagnosis of Glioblastoma and Primary Central Nervous System Lymphoma.
Clin Nucl Med. 2025 Jan 6. doi: 10.1097/RLU.0000000000005657. PMID: 39761437. Observational study˰ ˍ

Narsinh KH, Kumar K, Bankiewicz K, Martin AJ, Berger M, Clarke J, Taylor J, Bush NAO, Molinaro AM, Aghi M, Butowski N.
A phase I study of convection-enhanced delivery (CED) of liposomal-irinotecan using real-time magnetic resonance imaging in patients with recurrent high-grade glioma.
J Neurooncol. 2025 Jan 6. doi: 10.1007/s11060-024-04904-y. PMID: 39760796. Interventional study. ˍ

Suzuki M, Koga Y, Kawasaki T, Ueda T, Yamamoto S, Goto H, Kishimoto J, Ishida E, Todaka K, Sonoda KH, Oda Y, Koji Y, Sakai Y, Ohga S.
Access Program for Unapproved and Off-Label Drug Use in Pediatric BRAF V600E-Mutated Brain Tumors in Japan.
Pediatr Blood Cancer. 2025 Jan 6:e31510. doi: 10.1002/pbc.31510. PMID: 39762715. Interventional study. ˍ

Wu Y, Chen Z, Shi M, Qiu S, Zhang Y.
Nimotuzumab and bevacizumab combined with temozolomide and radiotherapy in patients with newly diagnosed glioblastoma multiforme: a retrospective single-arm study.
J Neurooncol. 2025 Jan 6. doi: 10.1007/s11060-024-04932-8. PMID: 39760795. Observational study˰ ˍ

Zhao XY, Yu JH, Wang YH, Liu YX, Xu L, Fu L, Yi N.
Lipomatous ependymoma with ZFTA: RELA fusion-positive: A case report.
World J Clin Cases. 2025 Jan 6;13(1):99746. doi: 10.12998/wjcc.v13.i1.99746. PMID: 39764539. Case report. ˍ

Dagar A, Ghosh A, Aashita, Kumar A, N YIK, Kamboj K, Sharma A, Raj J, Sharma D, Mallick S.
Survival and toxicity outcomes of hypofractionated conformal radiotherapy compared to conventionally fractionated radiotherapy in the treatment of diffuse intrinsic pontine gliomas.
Childs Nerv Syst. 2025 Jan 7;41(1):85. doi: 10.1007/s00381-024-06700-5. PMID: 39774994. Observational study˰ ˍ

Vitanza NA, Ronsley R, Choe M, Seidel K, Huang W, Rawlings-Rhea SD, Beam M, Steinmetzer L, Wilson AL, Brown C, Beebe A, Lindgren C, Gustafson JA, Wein A, Holtzclaw S, Hoeppner C, Goldstein HE, Browd SR, Hauptman JS, Lee A, Ojemann JG, Crotty EE, Leary SES, Perez FA, Wright JN, Alonso MM, Dun MD, Foster JB, Hurst D, Kong A, Thomsen A, Orentas RJ, Albert CM, Pinto N, Annesley C, Gardner RA, Ho O, Pattabhi S, Gust J, Wendler JP, Park JR, Jensen MC.
Intracerebroventricular B7-H3-targeting CAR T cells for diffuse intrinsic pontine glioma: a phase 1 trial.
Nat Med. 2025 Jan 7. doi: 10.1038/s41591-024-03451-3. PMID: 39775044. Interventional study. ˍ

Sedlák V, Němý M, Májovský M, Bubeníková A, Nordin LE, Moravec T, Engelová J, Sila D, Konečná D, Belšan T, Westman E, Netuka D.
IDH Status in Brain Gliomas Can Be Predicted by the Spherical Mean MRI Technique.
AJNR Am J Neuroradiol. 2025 Jan 8;46(1):121-128. doi: 10.3174/ajnr.A8432. PMID: 39779292. Observational study. ˍ

Xie J, Zhu Y, Yang Z, Yu Z, Yang M, Wang Q.
An integrative analysis reveals cancer risk associated with artificial sweeteners.
J Transl Med. 2025 Jan 8;23(1):32. doi: 10.1186/s12967-024-06047-0. PMID: 39780215. Observational study. ˍ

Seker S, Altay T, Uysal E, Cine HS, Yavuz AY, Avci I.
The correlation histopathological and conventional/advanced MRI techniques in glial tumors.
Cir Cir. 2025 Jan 9. doi: 10.24875/CIRU.23000648. PMID: 39787621. Observational study. ˍ

Shibuma S, On J, Natsumeda M, Koyama A, Takahashi H, Watanabe J, Mitobe M, Nakata S, Tanaka Y, Tsukamoto Y, Okada M, Yoshimura J, Tada M, Shimizu H, Oya S, Murai J, Okamoto K, Kawashima H, Kakita A, Oishi M.
Diagnosis of Leptomeningeal Disease in Diffuse Midline Gliomas by Detection of H3F3A K27M Mutation in Circulating Tumor DNA of Cerebrospinal Fluid.
Pediatr Blood Cancer. 2025 Jan 9:e31535. doi: 10.1002/pbc.31535. PMID: 39789738. Observational study˰ ˍ

Chen J, Shaw JM, Dhillon HM, Halkett GKB, McDougall E, Nowak AK, Campbell R; BRAINs Program Investigators.
Development of a brief screening measure of unmet supportive care needs (SCNS-P&C-6) in caregivers of people with high-grade glioma.
J Patient Rep Outcomes. 2025 Jan 10;9(1):6. doi: 10.1186/s41687-024-00835-4. PMID: 39792320. Observational study. ˍ

Kuroda H, Okita Y, Arisawa A, Utsugi R, Murakami K, Hirayama R, Kijima N, Arita H, Kinoshita M, Fujimoto Y, Nakamura H, Kagawa N, Tomiyama N, Kishima H.
Cerebral blood flow and histological analysis for the accurate differentiation of infiltrating tumor and vasogenic edema in glioblastoma.
PLoS One. 2025 Jan 10;20(1):e0316168. doi: 10.1371/journal.pone.0316168. PMID: 39792964. Observational study. ˍ

Sim Y, McClelland AC, Choi K, Han K, Park YW, Ahn SS, Chang JH, Kim SH, Gardner S, Lee SK, Jain R.
A comprehensive multicenter analysis of clinical, molecular, and imaging characteristics and outcomes of H3 K27-altered diffuse midline glioma in adults.
J Neurosurg. 2025 Jan 10:1-12. doi: 10.3171/2024.8.JNS241180. PMID: 39793011. Observational study˰ ˍ